See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Application · Mass Spectrometry

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10007975 (±)11,12-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 13.530276243094 -11-12-dhet-d11 (±)11,12-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)11,12-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 13.530276243094
10007266 (±)11,12-DHET Lipid Maps MS Standard - ≥98% 2009-02-11 59.770530386740 -11-12-dhet-lipid-maps-ms-standard (±)11,12-DiHETrE epoxides epoxygenases DHTs hydrolases (+/-)11,12-DiHETrEs MS mass spectrometry standards 59.770530386740
10006413 11(12)-EET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-25 32.847163904235 11-12-eet-d11 11(12)-EpETrE-d11 epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs deuterated deuterium 32.847163904235
10007262 11(12)-EET Lipid Maps MS Standard - ≥98% 2009-02-11 25.812527624309 11-12-eet-lipid-maps-ms-standard 11(12)-EpETrE epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs MS mass spectrometry standards 25.812527624309
319500 11-dehydro Thromboxane B2-d4 - ≥99% deuterated forms (d1-d4) 41.575980662983 11-dehydro-thromboxane-b2-d4 11-keto TXB2-d4 GC/MS deuterium isotopes 11-dh-TXB2-d4 internal standards thromboxanes 11-dehydro-TXB2-d4 deuterated GC-MS LC/MS LC-MS mass spectrometry atherosclerosis 41.575980662983
10007239 11-dehydro Thromboxane B2 Lipid Maps MS Standard 67910-12-7 ≥98% 2009-01-16 20.087947908445 11-dehydro-thromboxane-b2-lipid-maps-ms-standard 11-dehydro TXB2; 11-keto TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis MS mass spectrometry standards 20.087947908445
10006831 11-dehydro Thromboxane B2 Quant-PAK - 2005-08-08 25.818526703499 11-dehydro-thromboxane-b2-quant-pak Quant-PAKs metabolites thromboxanes plasma deuterium isotopes 11-dh-TXB2-d4 internal standards 11-dehydro-TXB2-d4 deuterated GC/MS GC-MS LC/MS LC-MS mass spectrometry atherosclerosis packs 25.818526703499
10009898 (−)-11-nor-9-carboxy-Δ9-THC-d3 (solution) 130381-15-6 ≥99% deuterated forms (d1-d3) 2010-11-12 8.249654696132 -11-nor-9-carboxy-9-thc-d3-solution THC metabolites Delta9-THC Δ9 THC tetrahydrocannabinols marijuana deuterateds deuterium internal standards mass spectrometry GC/MS LC/MS GC-MS LC-MS MS cannabinoids cbs synthetic 10916 8.249654696132
10007246 11(S)-HETE Lipid Maps MS Standard 54886-50-9 ≥98% 2009-02-17 4.907196132596 11-s-hete-lipid-maps-ms-standard hydroxy fatty acids 11-HETEs 11S-HETEs 11(S)-HETEs 11(S)HETEs 11-LOs 11-lipoxygenases MS mass spectrometry standards 4.907196132596
10008989 11β-Prostaglandin F2α-d4 - ≥99% deuterated forms (d1-d4) 2006-09-15 42.634342541436 11-prostaglandin-f2-d4 GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy signalling 11β-PGF2α 11βa-PGF2α metabolites PGD2 prostaglandins 9.beta.-11-deoxy-PGF2α 9beta-11-deoxy-PGF2α 9b-11-deoxy-PGF2alpha 42.634342541436
10007224 11β-Prostaglandin F2α Lipid Maps MS Standard 38432-87-0 >99% 2008-12-11 34.595414364640 11-prostaglandin-f2-lipid-maps-ms-standard 11β-PGF2α 11.beta.-PGF2.alpha. 11beta-PGF2alpha metabolites PGD2 prostaglandins 9.beta.-11-deoxy-PGF2.alpha. 9beta-11-deoxy-PGF2alpha MS Mass spectrometry standards 34.595414364640
10009994 (±)12,13-DiHOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-26 4.188692449355 -12-13-dihome-d4 Isoleukotoxin diol-d4 epoxides epoxygenase leukotoxin cytochrome P450 CYP450 sEH soluble epoxide hydrolase UGT glucuronidation UGT2B7 mass spectrometry MS deuterated deuterium 4.188692449355
10009996 12(13)-EpOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-04 3.260718232043 12-13-epome-d4 iso-Leukotoxin-d4; 12,13-EODE-d4 epoxides epoxygenases cytochrome P450 (+/-)12,13-EpOMEs (+/-)12(13)-EpOMEs epoxy fatty acids 3.260718232043
320135 12-epi Leukotriene B4-d4 - ≥99% deuterated forms (d1-d4) 94.801712707182 12-epi-leukotriene-b4-d4 12-epi LTB4-d4 12-epi-LTB4-d4 12(S)-LTB4-d4 12(S)LTB4-d4 12S-LTB4-d4 leukotrienes mass spectrometry GC/MS LC/MS GC-MS LC-MS internal standards deuterated deuterium isotopes 94.801712707182
10007249 12-OxoETE Lipid Maps MS Standard 108437-64-5 ≥90% 2009-02-18 24.333802946593 12-oxoete-lipid-maps-ms-standard 12-KETE HETEs metabolites 12-KETEs chemotactic 12-OxoETEs fatty acids oxo-acids 12-oxo-ETEs MS mass spectrometry standards 24.333802946593
10007247 12(R)-HETE Lipid Maps MS Standard 82337-46-0 ≥98% 2009-02-17 21.069848066298 12-r-hete-lipid-maps-ms-standard hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases MS mass spectrometry standards 21.069848066298
334570 12(S)-HETE-d8 84807-90-9 ≥99% deuterated forms (d1-d8) 39.844961325967 12-s-hete-d8 GC/MS deuterium isotopes 12-HETE-d8 standards12S-HETE-d8 deuterated GC-MS LC/MS LC-MS 12-HETEs 12(S)-HETEs 12S-HETEs 12(S)HETEs hydroxy fatty acids 12(S)HETE-d8 mass spectrometry 39.844961325967
10007248 12(S)-HETE Lipid Maps MS Standard 54397-83-0 ≥98% 2009-02-18 21.392574585635 12-s-hete-lipid-maps-ms-standard 12-HETEs 12-LOs pig leukocytes platelets human 12S-HETEs 12-lipoxygenases 12(S)-HETEs porcine hydroxy fatty acids 12(S)HETEs MS mass spectrometry standards 21.392574585635
10007250 12(S)-HHTrE Lipid Maps MS Standard 54397-84-1 ≥97% 2009-02-26 30.234077348066 12-s-hhtre-lipid-maps-ms-standard 12-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis MS mass spectrometry standards 30.234077348066
10007258 12(S)-HpETE Lipid Maps MS Standard 71774-10-2 ≥98% 2009-02-02 13.373845303867 12-s-hpete-lipid-maps-ms-standard 12-LOs 12-HpETEs 12S-HpETEs hydroperoxides 12-lipoxygenases 12(S)-HpETEs monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standard 13.373845303867
10007978 13,14-dihydro-15-keto Prostaglandin D2-d4 - ≥99% deuterated forms (d1-d4) 2006-02-10 101.183812154696 13-14-dihydro-15-keto-prostaglandin-d2-d4 13,14-dihydro-15-keto PGD2-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry metabolites 13,14-dihydro-15-keto-PGD2 prostaglandins 101.183812154696
10007208 13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard 59894-07-4 >98% 2008-10-29 35.378618784530 13-14-dihydro-15-keto-prostaglandin-d2-lipid-maps-ms-standard 13,14-dihydro-15-keto PGD2 metabolites 13,14-dihydro-15-keto-PGD2 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 35.378618784530
9000288 13,14-dihydro-15-keto Prostaglandin E1-d4 - ≥99% deuterated forms (d1-d4) 2004-05-05 48.105447513812 13-14-dihydro-15-keto-prostaglandin-e1-d4 13,14-dh-15-k PGE1-d4 PGE0 metabolites 13,14-dihydro-15-ketoPGE1 prostaglandins deuterium deuterateds 48.105447513812
10010606 13,14-dihydro-15-keto Prostaglandin E2-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2008-03-18 23.639152854512 13-14-dihydro-15-keto-prostaglandin-e2-d4 13,14-dh-15-keto PGE2-d4 deuterated metabolites 13,14-dihydro-15-keto-PGE2 prostaglandins PGE2 deuterium 23.639152854512
10007214 13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard 363-23-5 >98% 2008-11-12 41.432364640884 13-14-dihydro-15-keto-prostaglandin-e2-lipid-maps-ms-standard 13,14-dihydro-15-keto PGE2 metabolites 13,14-dihydro-15-keto-PGE2 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 41.432364640884
10007793 13,14-dihydro-15-keto Prostaglandin F2α-d4 - ≥99% deuterated forms (d1-d4) 2006-02-06 16.382958312406 13-14-dihydro-15-keto-prostaglandin-f2-d4 PGFM-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 13,14-dihydro-15-keto-PGF2a 13,14-dihydro-15-keto-PGF2.alpha. metabolites prostaglandins 16.382958312406
10007226 13,14-dihydro-15-keto Prostaglandin F2α Lipid Maps MS Standard 27376-76-7 >99% 2008-12-04 4.260740331491 13-14-dihydro-15-keto-prostaglandin-f2-lipid-maps-ms-standard 13,14-dihydro-15-keto PGF2α; PGFM; 13,14-dh-15-k PGF2α 13,14-dihydro-15-keto-PGF2alpha 13,14-dihydro-15-keto-PGF2.alpha. metabolites prostaglandins MS mass spectrometry PGs marker plasma 4.260740331491
9000281 13,14-dihydro Prostaglandin E1-d4 - ≥99% deuterated forms (d1-d4) 2004-05-06 41.217624309392 13-14-dihydro-prostaglandin-e1-d4 13,14-dh PGE1-d4; Prostaglandin E0-D4 PGE0 metabolites 13,14-dihydro-PGE1 prostaglandins GC/MS deuterium isotopes PGA2-d4 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry gas liquid chromatography spectroscopy 41.217624309392
338620 13-OxoODE-d3 - ≥99% deuterated forms (d1-d3) 2011-11-11 7.245543278085 13-oxoode-d3 13-KODE-d3 13-KODEs fatty metabolites 13-OxoODEs 13-oxo-ODEs oxo-acids deuterateds deuterium mass spectrometry LC-MS LC/MS NAD+ rats colonic cells proliferation oxo-fatty 13-HODEs HODEs NAD dependent dehydrogenase mucosa intra-rectally intrarectally maturation reticulocytes erythrocytes 15-LO 15-lipoxygenase OxoODEs 7.245543278085
338610 13(S)-HODE-d4 139408-39-2 ≥99% deuterated forms (d1-d4) 38.766077348066 13-s-hode-d4 GC/MS deuterium isotopes 13-HODE-d4 standards 13S-HODE-d4 deuterated GC-MS LC/MS LC-MS 13-HODEs 13(S)-HODEs 13S-HODEs 13(S)HODEs hydroxy fatty acids 13(S)HODE-d4 mass spectrometry 38.766077348066
10008040 (±)14,15-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-18 29.655414364641 -14-15-dhet-d11 (±)14,15-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterium 29.655414364641
10007267 (±)14,15-DHET Lipid Maps MS Standard - >98% 2009-01-06 27.189834254144 -14-15-dhet-lipid-maps-ms-standard (±)14,15-DiHETrE epoxides epoxygenases DHTs hydrolases (+/-)14,15-DiHETrEs MS mass spectrometry standards 27.189834254144
10006410 14(15)-EET-d11 - ≥99% deuterated forms (d1-d11) 2007-07-22 91.322375690608 14-15-eet-d11 14(15)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (+/-)14(15)-EpETrEs (+/-)5,6-EpETrEs fatty acids deuterated deuterium CYP450 mass spectrometry MS 14,15-EETs biosynthesized liver microsomes pregnancy hypertension 91.322375690608
10007263 14(15)-EET Lipid Maps MS Standard - ≥98% 2009-02-11 17.208238182934 14-15-eet-lipid-maps-ms-standard 14(15)-EpETrE epoxides epoxygenases 14,15-EETs cytochrome P450 (+/-)14,15-EpETrEs (+/-)14(15)-EpETrEs MS mass spectrometry standards 17.208238182934
318570 15-deoxy-Δ12,14-Prostaglandin J2-d4 - ≥99% deuterated forms (d1-d4) 30.284861878453 15-deoxy-12-14-prostaglandin-j2-d4 15-deoxy-Δ12,14-PGJ2-d4 GC/MS deuterium isotopes 15-deoxy-DELTA12,14-PGJ2-d4 15-deoxy-.DELTA.12,14-PGJ2-d4 15-deoxy-D12,14-PGJ2-d4 internal standards prostaglandins deuterated mass spectrometry GC-MS LC-MS LC/MS atherosclerosis 30.284861878453
10007235 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard 87893-55-8 ≥97% 2009-01-16 38.002247928177 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards 38.002247928177
10007215 15-keto Prostaglandin E2 Lipid Maps MS Standard 26441-05-4 >99% 2008-12-15 71.866482504604 15-keto-prostaglandin-e2-lipid-maps-ms-standard 15-keto PGE2 15-keto-PGE2 metabolites prostaglandins MS mass spectrometry standards PGs inactive 71.866482504604
10007227 15-keto Prostaglandin F2α Lipid Maps MS Standard 35850-13-6 >98% 2008-12-18 16.821837016574 15-keto-prostaglandin-f2-lipid-maps-ms-standard 15-keto PGF2α 15-keto-PGF2alpha 15-keto-PGF2.alpha. metabolites prostaglandins endocrinology PGs PGF2α MS Mass Spectrometry 16.821837016574
334720 15(S)-HETE-d8 84807-87-4 ≥99% deuterated forms (d1-d8) 33.119594843463 15-s-hete-d8 GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE 33.119594843463
10007251 15(S)-HETE Lipid Maps MS Standard 54845-95-3 ≥98% 2009-02-17 16.312885677858 15-s-hete-lipid-maps-ms-standard soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE 16.312885677858
10007259 15(S)-HpETE Lipid Maps MS Standard 70981-96-3 >98% 2009-02-10 9.112486187845 15-s-hpete-lipid-maps-ms-standard 15-LOs 15-HpETEs 15S-HpETEs hydroperoxides 15(S)-HpETEs 15(S)HPETEs 15-lipoxygenases monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standards 9.112486187845
316810 17-phenyl trinor Prostaglandin F2α-d4 - ≥99% deuterated forms (d1-d4) 30.387140883977 17-phenyl-trinor-prostaglandin-f2-d4 17-phenyl trinor PGF2α-d4; Bimatoprost (free acid)-d4 GC/MS deuterium isotopes 17-phenyl-trinor-PGF2.alpha.-3,3,4,4-d4 17-pheny-trinor-PGF2alpha-3,3,4,4-d4 GC-MS LS/MS LC-MS mass spectrometry spectroscopy chromatography deuterateds 30.387140883977
316820 17-phenyl trinor Prostaglandin F2α ethyl amide-d4 - ≥99% deuterated forms (d1-d4) 53.555298844801 17-phenyl-trinor-prostaglandin-f2-ethyl-amide-d4 17-phenyl trinor PGF2α ethyl amide-d4; Bimatoprost-d4 GC/MS deuterium isotopes 8-isoprostanes 17-phenyl-trinor-PGF2.alpha.-3,3,4,4-d4 17-phenyl-trinor-PGF2alpha-3,3,4,4-d4 GC-MS LS/MS LC-MS mass spectrometry spectroscopy chromatography deuterateds 53.555298844801
10007217 19(R)-hydroxy Prostaglandin E2 Lipid Maps MS Standard 64625-54-3 >98% 2008-12-17 64.781325966850 19-r-hydroxy-prostaglandin-e2-lipid-maps-ms-standard 19(R)-OH PGE2; 19(R)-hydroxy PGE2 19(R)-hydroxy-PGE2 19(R)-OH-PGE2 19R-hydroxy-PGE2 19R-OH-PGE2 metabolites semen agonists EP2 prostaglandins receptors hydroxylated PGs MS mass spectrometry standards 64.781325966850
362152 1-Arachidonoyl Glycerol-d5 - ≥99% deuterated forms (d1-d5) 36.490704419889 1-arachidonoyl-glycerol-d5 1-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic 36.490704419889
10009431 1-Stearoyl-2-Arachidonoyl PC-d8 Exclusive - ≥99% deuterated forms (d1-d8) ✓ 2009-07-24 8.713674033149 1-stearoyl-2-arachidonoyl-pc-d8 SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards 8.713674033149
390030 20-HETE-d6 - ≥99% deuterated forms (d1-d6) 94.095276243094 20-hete-d6 20-hydroxy Arachidonic Acid-d6 CYP450 vasocontriction standards vasoconstrictors GC-MS GC/MS LC-MS LC/MS cytochrome chromatography mass spectroscopy deuterium deuterateds 94.095276243094
10007269 20-HETE Lipid Maps MS Standard 79551-86-3 ≥98% 2009-02-18 22.238900552486 20-hete-lipid-maps-ms-standard 20-hydroxy Arachidonic Acid hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction MS mass spectrometry standards 22.238900552486
10007218 20-hydroxy Prostaglandin E2 Lipid Maps MS Standard 57930-95-7 ≥98% 2008-12-15 97.662734806630 20-hydroxy-prostaglandin-e2-lipid-maps-ms-standard 20-hydroxy PGE2 20-hydroxy-PGE2 20-OH-PGE2 metabolites prostaglandins hydroxylated MS mass spectrometry standards PGs intermediates 97.662734806630
10007229 20-hydroxy Prostaglandin F2α Lipid Maps MS Standard 57930-92-4 ≥98% 2009-01-28 16.950736648250 20-hydroxy-prostaglandin-f2-lipid-maps-ms-standard 20-hydroxy PGF2α 20-hydroxy-PGF2alpha 20-hydroxy-PGF2.alpha. prostaglandins hydroxylated 20-OH-PGF2.alpha. 20-OH-PGF2alpha MS mass spectrometry PGs 16.950736648250
10007225 2,3-dinor-11β-Prostaglandin F2α Lipid Maps MS Standard 240405-20-3 >98% 2008-12-17 67.957988950276 2-3-dinor-11-prostaglandin-f2-lipid-maps-ms-standard 2,3-dinor-11β-PGF2α 2,3-dinor-11.beta.-PGF2.alpha. 2,3-dinor-11beta-PGF2alpha 2,3-dinor-11b-PGF2alpha prostaglandins urine PGD2 asthmatic asthma urinary PGs 2,3-dinor-11β-PGF2α MS mass spectrometry standards 67.957988950276
13049 2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid 144060-98-0 ≥98% 2009-02-14 0.059852670349 2-4-pyridyl-4-methyl-thiazole-5-carboxylic-acid BR Labs pyrimidines acids intermediates synthetic 0.059852670349
11099 25-hydroxy Cholesterol-d6 New 88247-69-2 ≥99% deuterated forms (d1-d6) 2012-01-27 0.241974626560 25-hydroxy-cholesterol-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 0.241974626560
362162 2-Arachidonoyl Glycerol-d5 - ≥99% deuterated forms (d1-d5) 47.930980662983 2-arachidonoyl-glycerol-d5 2-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 47.930980662983
362160 2-Arachidonoyl Glycerol-d8 - ≥99% deuterated forms (d1-d8) 84.020801104972 2-arachidonoyl-glycerol-d8 2-AG-d8 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 84.020801104972
10918 (±)3-epi CP 47,497-C8-homolog - ≥98% 2011-05-06 9.598423751790 -3-epi-cp-47-497-c8-homolog (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 9.598423751790
13802 (±)3-epi CP 47,497-C8-homolog (solution) Exclusive - ≥98% ✓ 2010-08-04 9.270452402875 -3-epi-cp-47-497-c8-homolog-solution (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 9.270452402875
9000368 3-hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium salt) Exclusive - ≥99% deuterated forms (d1-d3) ✓ 2009-04-20 12.643646408840 3-hydroxy-3-methylglutaryl-coenzyme-a-d3-ammonium-salt HMG-CoA-d3 HMG-CoA mevalonic acid mevalonate cholesterol steroids sterols deuterateds deuterium standards GC MS LC mass spetrometry 12.643646408840
13006 3-methyl-2-Quinoxalinone 14003-34-0 ≥98% 2009-02-14 0E-12 3-methyl-2-quinoxalinone NSC 149824; NSC 17798; NSC 38589 BR Labs pyrimidines acids intermediates synthetic 0E-12
9000981 4-chloro-α-Cyanocinnamic Acid 20374-46-3 ≥98% 2011-09-30 8.078232044199 4-chloro-cyanocinnamic-acid CI-CCA matrix-assisted laser desorption/ionization MALDI mass spectrometry MS matrix sensitivity peptides proteins analysis CICCA 8.078232044199
332101 4-hydroxy Nonenal-d3 - ≥99% deuterated forms (d1-d3) 2004-01-28 41.869250197316 4-hydroxy-nonenal-d3 4-HNE-d3 ROS alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-nonenal 4-hydroxynonenal deuterium deuterateds 41.869250197316
9000876 4-hydroxy Nonenal Glutathione-d3 Exclusive - ≥99% deuterated forms (d1-d3) ✓ 2010-10-29 9.519444444444 4-hydroxy-nonenal-glutathione-d3 4-HNE-GSH-d3 oxidative stress lipids peroxidation 4-hydroxy nonenal 4-HNE deuterateds GSH-HNE internal standards mass spectrometry HNE-GSH-d3 deuteriums GC/MS LC/MS LC-MS MS 9.519444444444
10004174 4-oxo 2-Nonenal-d3 Exclusive - ≥99% deuterated forms (d1-d3) ✓ 2004-03-10 32.266666666666 4-oxo-2-nonenal-d3 4-ONE-d3 ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds 32.266666666666
10007264 (±)5,6-DHET Lipid Maps MS Standard - ≥98% 2009-02-14 7.077085635359 -5-6-dhet-lipid-maps-ms-standard (±)5,6-DiHETrE epoxides epoxygenases DHT hydrolases (+/-)5,6-DiHETrEs MS mass spectrometry standards 7.077085635359
10009984 5(6)-EET-d11 - ≥99% deuterated forms (d1-d11) 2007-06-06 15.434309392266 5-6-eet-d11 5(6)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids deuterated deuterium 15.434309392266
10007260 5(6)-EET Lipid Maps MS Standard - ≥98% 2009-02-05 6.893591160221 5-6-eet-lipid-maps-ms-standard 5(6)-EpETrE epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids MS mass spectrometry standards 6.893591160221
13803 (±)5-epi CP 55,940 - ≥98% 2010-08-04 8.949804118533 -5-epi-cp-55-940 (±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 8.949804118533
10006654 5-iPF2α-VI-d11 - ≥99% deuterated forms (d1-d11) 2005-03-17 122.834497237569 5-ipf2-vi-d11 isoprostanes peroxidation oxidative injury deuterateds deuteriums isotopes 8,12-isoprostanes iPF2alpha-VI-d11 prostaglandins iPF2a-VI-d11 urine peroxidative damage enantiomers stress 122.834497237569
334250 5-OxoETE-d7 - ≥99% deuterated forms (d1-d7) 21.702707182320 5-oxoete-d7 5-KETE-d7 GC/MS deuterium isotopes 5-KETEs oxo-acids 5oxoetes 5ketes 5-oxo-ete-d7 standards fatty LC/MS GC-MS LC-MS mass spectrometry deuterated 5-oxoETEs 21.702707182320
10007244 5-OxoETE Lipid Maps MS Standard 106154-18-1 >95% 2009-01-05 10.319511970533 5-oxoete-lipid-maps-ms-standard 5-KETE 5-HETEs oxo-acids 5-LOs metabolites chemotactic fatty 5-lipoxygenases 5-oxo-etes polyunsaturated PUFAs MS mass spectrometry standards 10.319511970533
10007255 5(S),15(S)-DiHETE Lipid Maps MS Standard 82200-87-1 ≥98% 2009-02-18 2.367826887661 5-s-15-s-dihete-lipid-maps-ms-standard 15-LOs dihydroxy fatty acids 15-lipoxygenases 5S,15S-DiHETEs 5,15-DiHETEs 5(S),15(S)-DiHETEs MS mass spectrometry standards 2.367826887661
10007252 5(S),6(R)-DiHETE Lipid Maps MS Standard 82948-88-7 >99% 2009-02-17 3.262965009208 5-s-6-r-dihete-lipid-maps-ms-standard LTA4 hydrolysis DHT 5S,6R-DiHETEs 5(S),6(R)-DiHETEs 5,6-DiHETEs MS mass spectrometry standards 3.262965009208
10007737 5(S),6(R)-Lipoxin A4-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2009-04-09 43.384917127072 5-s-6-r-lipoxin-a4-d5 5(S),6(R)-LXA4-d5; 5(S),6(R),15(S)-TriHETE-d5 LXA4 lipoxins trihydroxy fatty acids leukocytes activation deuterated deuteriums MS LC mass spectrometry standards GC 43.384917127072
10007271 5(S),6(R)-Lipoxin A4 Lipid Maps MS Standard 89663-86-5 ≥95% 2009-02-18 37.582744014733 5-s-6-r-lipoxin-a4-lipid-maps-ms-standard 5(S),6(R),15(S)-TriHETE; 5(S),6(R)-LXA4 LXA4 lipoxins trihydroxy fatty acids leukocytes activation MS mass spectrometry standards 37.582744014733
10007253 5(S),6(S)-DiHETE Lipid Maps MS Standard 82948-87-6 ≥98% 2009-02-17 2.406058931860 5-s-6-s-dihete-lipid-maps-ms-standard LTA4 hydrolysis DHT 5S,6S-DiHETEs 5(S),6(S)-DiHETEs 5,6-DiHETEs MS mass spectrometry standards 2.406058931860
334230 5(S)-HETE-d8 330796-62-8 ≥99% deuterated forms (d1-d8) 25.102223756906 5-s-hete-d8 GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 25.102223756906
10007276 5(S)-HETE-d8 Lipid Maps MS Standard - ≥99% deuterated product 2009-02-26 22.268632596685 5-s-hete-d8-lipid-maps-ms-standard GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 22.268632596685
10007243 5(S)-HETE Lipid Maps MS Standard 70608-72-9 >98% 2009-01-06 21.821860036832 5-s-hete-lipid-maps-ms-standard arachidonic 5-lipoxygenases 5-LOs hydroxy acids 5S-HETEs 5-HETEs 5(S)-HETEs 5(S)HETEs fatty MS mass spectrometry standards 21.821860036832
10007257 5(S)-HpETE Lipid Maps MS Standard 71774-08-8 ≥98% 2009-02-04 7.518397790055 5-s-hpete-lipid-maps-ms-standard 5-LOs 5-HpETEs hydroperoxides 5S-HpETEs 5(S)HpETEs hydroperoxy 5-lipoxygenases 5(S)-HpETEs arachidonic fatty acids leukotrienes MS mass spectrometry standards 7.518397790055
10742 5(Z),8(Z),11(Z)-Eicosatrienoic Acid-d6 Exclusive - ≥99% deuterated forms (d1-d6) ✓ 2011-06-28 2.530957642725 5-z-8-z-11-z-eicosatrienoic-acid-d6 Mead Acid-d6 standards GC-MS GC/MS LC-MS LC/MS mass spectroscopy deuterium deuterateds fatty acids deficient PUFAs omega-3 omega-6 omega 6 omega 3 polyunsaturated ω-3 ω-6 ω3 ω6 ω 3 ω 6 2.530957642725
10007220 6,15-diketo-13,14-dihydro Prostaglandin F1α Lipid Maps MS Standard 63983-53-9 >98% 2008-12-13 27.039760589318 6-15-diketo-13-14-dihydro-prostaglandin-f1-lipid-maps-ms-standard 6,15-diketo-13,14-dihydro PGF1α MS Mass Spectrometry 6,15-diketo-13,14-dihydro-PGF1α 6,15-diketo-13,14-dihydro-PGF1alpha prostaglandins metabolites 27.039760589318
10007210 6-keto Prostaglandin E1 Lipid Maps MS Standard 67786-53-2 >99% 2008-11-03 40.630294659300 6-keto-prostaglandin-e1-lipid-maps-ms-standard 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 40.630294659300
315210 6-keto Prostaglandin F1α-d4 - ≥99% deuterated forms (d1-d4) 19.680176795580 6-keto-prostaglandin-f1-d4 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 19.680176795580
10007274 6-keto Prostaglandin F1α-d4 Lipid Maps MS Standard - ≥99% deuterated forms (d1-d4) 2009-02-26 53.985220994474 6-keto-prostaglandin-f1-d4-lipid-maps-ms-standard 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 53.985220994474
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 39.352254143646 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 39.352254143646
10007256 6-trans-12-epi Leukotriene B4 Lipid Maps MS Standard 71548-19-1 ≥97% 2009-01-28 37.374486187845 6-trans-12-epi-leukotriene-b4-lipid-maps-ms-standard 6-trans-12-epi LTB4; 5(S),12(S)-DiHETE leukotrienes 6-trans-12-epi-LTB4 isomers LTA4 hydrolysis LTs MS mass spectrometry standards 37.374486187845
10007254 6-trans Leukotriene B4 Lipid Maps MS Standard 71652-82-9 ≥97% 2009-02-17 68.115003946330 6-trans-leukotriene-b4-lipid-maps-ms-standard All trans LTB4; 6-trans LTB4; 5(S),12(R)-DiHETE leukotrienes 6-trans-LTB4 LTA4 hydrolysis MS mass spectrometry standards 68.115003946330
10010670 7-Aminoclonazepam-d4 - ≥99% deuterated product 2009-04-17 7.863259668508 7-aminoclonazepam-d4 seizures myotonic atonic epilepsy receptors acids deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 7.863259668508
10006878 8,12-iso-iPF2α-VI-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2005-09-01 7.929696132596 8-12-iso-ipf2-vi-d11 8,12-epi-iPF2α-VI-d11 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience 7.929696132596
10009998 (±)8,9-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 10.037569060774 -8-9-dhet-d11 (±)8,9-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 10.037569060774
10007265 (±)8,9-DHET Lipid Maps MS Standard - ≥98% 2009-02-11 7.875290055248 -8-9-dhet-lipid-maps-ms-standard (±)8,9-DiHETrE epoxides epoxygenases DHT hydrolases (+/-)8,9-DiHETrEs MS mass spectrometry standards 7.875290055248
10009532 8(9)-EET-d11 - ≥99% deuterated forms (d1-d11) 2008-03-25 11.298416206261 8-9-eet-d11 8(9)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs deuterated racemic mixture 11.298416206261
10007261 8(9)-EET Lipid Maps MS Standard - ≥98% 2009-02-10 7.764331491712 8-9-eet-lipid-maps-ms-standard 8(9)-EpETrE epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs MS mass spectrometry standards 7.764331491712
10011321 8-iso Prostaglandin E2-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2008-08-14 5.495773480663 8-iso-prostaglandin-e2-d4 8-iso PGE2-d4; 8-epi PGE2-d4 8-isoprostanes 8-epi-PGE2 8-iso-PGE2 renal vasoconstriction prostaglandins deuteriums deuterateds 5.495773480663
10008935 8-iso Prostaglandin F1α-d9 - ≥99% deuterated forms (d1-d9) 2006-09-15 8.528508287292 8-iso-prostaglandin-f1-d9 8-epi PGF1α-d9 GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy signalling 8-isoprostanes 8-epi-PGF1.alpha. 8-epi-PGF1alpha 8-iso-PGF1.alpha. 8-iso-PGF1alpha prostaglandins 8.528508287292
316350 8-iso Prostaglandin F2α-d4 211105-40-7 ≥99% deuterated forms (d1- d4) 101.686063535911 8-iso-prostaglandin-f2-d4 15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4 GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 101.686063535911
10007245 8(S)-HETE Lipid Maps MS Standard 98462-03-4 >98% 2009-01-05 3.198243093922 8-s-hete-lipid-maps-ms-standard hydroxy acids 8S-HETEs 8-HETEs fatty 8(S)-HETEs 8(S)HETEs MS mass spectrometry standards 3.198243093922
10009993 (±)9,10-DiHOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-01 3.843232044199 -9-10-dihome-d4 Leukotoxin diol-d4 epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 deuterated duteriums 3.843232044199
10009995 9(10)-EpOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-01 3.026095764272 9-10-epome-d4 Leukotoxin-d4; 9,10-EODE-d4 epoxides epoxygenasse leukotoxin cytochrome P450 (+/-)9(10)-EpOMEs (+/-)9,10-EpOMEs epoxy fatty acids deuterated deuterium 3.026095764272
338420 9-OxoODE-d3 - ≥99% deuterated forms (d1- d3) 2011-11-11 7.530257826887 9-oxoode-d3 9-KODE-d3 9-KODEs metabolites oxo-acids metabolites fatty 9-OxoODEs 9-oxo-ODEs deuterateds deuterium mass spectrometry LC-MS LC/MS reticulocyte mitochondrial plasma membranes lipids LC MS 15-LO OxoODEs 15-lipoxygenase linoleate residues acids oxo-fatty 7.530257826887
338410 9(S)-HODE-d4 - ≥99% deuterated forms (d1- d4) 20.920441988950 9-s-hode-d4 GC/MS deuterium isotopes 9-HODE-d4 standards 9S-HODE-d4 deuterated GC-MS LC/MS LC-MS 9-HODEs 9(S)-HODEs 9S-HODEs 9(S)HODES hydroxy fatty acids 9(S)HODE-d4 mass spectrometry 20.920441988950
10706 AM2201-d5 Exclusive - ≥99% deuterated forms (d1- d5) ✓ 2011-05-16 53.678816923285 am2201-d5 cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 53.678816923285
11457 AM2201 N-(4-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-03-13 109.116260245029 am2201-n-4-hydroxypentyl-metabolite-d5 cannabinoids central peripheral metabolites CB1 CB2 receptors pain forensic sciences synthetics smoking urinary urine potent CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 109.116260245029
10010668 Amiodarone-d4 (hydrochloride) - ≥99% deuterated forms (d1-d4) 2009-06-25 0E-12 amiodarone-d4-hydrochloride deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry drugs inhibitors inhibits inhibition heart rate muscles 19774-82-4 0E-12
10010663 Amlodipine-d4 (besylate) - ≥99% deuterated forms (d1-d4) 2009-08-10 0E-12 amlodipine-d4-besylate deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry dihydropyridine pyridines calcium channel blocker angina pectoris hypertension 88150-42-9 0E-12
710000 AMP+ Mass Spectrometry Kit - 2010-09-13 1.602209944751 amp-mass-spectrometry-kit GELB Derivitization Kit 1.602209944751
390010 Arachidonic Acid-d8 69254-37-1 ≥99% deuterated forms (d1-d8) 209.218998618785 arachidonic-acid-d8 standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated 209.218998618785
10007277 Arachidonic Acid-d8 Lipid Maps MS Standard 69254-37-1 ≥99% deuterated forms (d1-d8) 2009-03-02 84.566885359116 arachidonic-acid-d8-lipid-maps-ms-standard standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated 84.566885359116
10007268 Arachidonic Acid Lipid Maps MS Standard 506-32-1 ≥98% 2009-07-06 18.887808471454 arachidonic-acid-lipid-maps-ms-standard fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential MS mass spectrometry standards 18.887808471454
390014 Arachidonic Acid methyl ester-d8 Exclusive - ≥99% deuterated forms (d1-d8) ✓ 2010-02-12 17.645138121547 arachidonic-acid-methyl-ester-d8 Methyl Arachidonate-d8 PUFA FAME polyunsaturated fatty acids esters GC exogenous 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic diets dietary arachidonates essential deuterateds deuteriums standards LC/MS MS mass spectrometry GC/MS LC-MS GC-MS 17.645138121547
10011178 Arachidonoyl Ethanolamide-d4 946524-40-9 ≥99% deuterated forms (d1-d4) 2008-03-04 40.586823204420 arachidonoyl-ethanolamide-d4 AEA-d4; Anandamide-d4 deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 40.586823204420
390050 Arachidonoyl Ethanolamide-d8 - ≥99% deuterated forms (d1-d8) 42.214751381215 arachidonoyl-ethanolamide-d8 Anandamide-d8; AEA-d8 deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology 42.214751381215
10007270 Arachidonoyl Ethanolamide Lipid Maps MS Standard 94421-68-8 ≥98% 2009-02-18 7.096138971526 arachidonoyl-ethanolamide-lipid-maps-ms-standard AEA; Anandamide cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology MS mass spectrometry standards 7.096138971526
10007531 Arachidonoyl Glycine-d8 - ≥99% deuterated forms (d1-d8) 2005-09-13 17.205649171270 arachidonoyl-glycine-d8 N-Arachidonyl Glycine-d8; NAGly-d8 deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience 17.205649171270
10007213 Bicyclo Prostaglandin E2 Lipid Maps MS Standard 7415-09-1 >98% 2008-11-05 2.723121546961 bicyclo-prostaglandin-e2-lipid-maps-ms-standard Bicyclo PGE2 bicyclo-PGE2 metabolites prostaglandins bicyclo GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 2.723121546961
9000528 Bromoenol lactone-d7 - ≥99% deuterated forms (d1-d7) 2010-06-21 15.601223362273 bromoenol-lactone-d7 Haloenol lactone-d7; HELSS-d7; BEL-d7 selective iPLA2 inhibitors phospholipases PLAs deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS inhibited inhibition 15.601223362273
10010681 Capecitabine-d11 - ≥99% deuterated forms (d1-d11) 2009-03-04 18.888888888889 capecitabine-d11 154361-50-9 5-DFCR 5'-DFCR 5-DFUR 5'-DFUR 5'-deoxy-5-fluorocytidine 5'-deoxy-5-fluororidine SPI BIO 154361-50-9 18.888888888889
10010685 Capecitabine-d8 - ≥99% deuterated forms (d1-d8) 2009-03-04 18.888888888889 capecitabine-d8 154361-50-9 5-DFCR 5'-DFCR 5-DFUR 5'-DFUR 5'-deoxy-5-fluorocytidine 5'-deoxy-5-fluororidine SPI BIO 154361-50-9 18.888888888889
10009523 CAY10429-d3 - ≥99% deuterated forms (d1-d3) 2007-10-02 4.785082872929 cay10429-d3 Abnormal Cannabidiol-d3; Abn-CBD-d3 endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic 4.785082872929
9000595 CEP-Lysine-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-08-23 31.147900552486 cep-lysine-d4 Docosahexaenoic acid DHA oxidative stress 2-(ω-carboxyethyl)pyrrole CEP carboxyethylpyrrole advanced glycation end products biomarkers age-related macular degeneration deuterateds internal standard GC LC chromatography mass spectrometry GC-MS LC-MS GC/MS LC/MS deuterium 31.147900552486
10686 (±)-CP 47,497-C8-homolog-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-14 25.726973152059 -cp-47-497-c8-homolog-d7-solution Cannabicyclohexanol-d7 cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 25.726973152059
10687 (±)-CP 47,497-d11 (solution) Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2011-02-16 34.319074410242 -cp-47-497-d11-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 34.319074410242
10249 Deoxy-5-fluorocytidine-D2 New 66335-38-4 ≥99% deuterated forms (d1-d2) 2012-01-19 18.888888888889 deoxy-5-fluorocytidine-d2 5-DFCR-D2 SPI BIO deuterateds deuterium chemotherapy breasts colon cancers prodrugs 5-fluorouracil tumors DNA growth tissues enzymes metabolites 5'-deoxy-5-fluorocytidine 5'-deoxy-5-fluorouridine 5'-DFCR 5'-DFUR 1226642-70-1 18.888888888889
10007901 D-erythro-Sphingosine C-15 86555-28-4 ≥98% 2010-08-20 4.873907584128 d-erythro-sphingosine-c-15 sphingosines internal standard 10007907 unsaturated hydrocarbon chain 18-carbon 18 carbons dihydrosphingosine mammalian tissues 4.873907584128
10007902 D-erythro-Sphingosine C-17 6918-48-5 ≥98% 2010-08-20 3.431315921647 d-erythro-sphingosine-c-17 sphingosines kinases internal standard C17 C 17 human skin sphingoid chromatographic spectrometric dihydrosphingosine 10007907 3.431315921647
10458 Dihomo-γ-Linolenic Acid-d6 Exclusive - ≥99% deuterated forms (d1-d6) ✓ 2011-06-13 13.281111111111 dihomo-linolenic-acid-d6 DGLA-d6 deuterated LC/MS GC-MS LC-MS mass spectrometry polyunsaturated dihomo-g-linolenic dihomo-γ-linolenic dihomo-gamma-linolenic omega-6 ω-6 fatty acids antagonists arachidonic receptors LTB4 deuterium 13.281111111111
10010669 Dihydrobupropion-d9 - ≥99% deuterated forms (d1-d9) 2009-04-17 11.113259668508 dihydrobupropion-d9 aminoketone ketones antideppressant dopamine smoking cessation treatment deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 11.113259668508
10696 dinor-12-oxo Phytodienoic Acid-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-04-04 35.514116914182 dinor-12-oxo-phytodienoic-acid-d5 dinor-12-oxo PDA-d5; dinor-OPDA-d5 jasmonates pathways plants hormones senescence development intermediates jasmonic acids glycerolipids galactolipids arabidopsides dnOPDA dn-OPDA deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS LC GC standards 35.514116914182
11219 DMABA-d10 NHS ester New 1175002-05-7 9% deuterated forms (d1-d10) 2012-02-15 0E-12 dmaba-d10-nhs-ester GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers 0E-12
11217 DMABA-d4 NHS ester New 1175002-03-5 ≥99% deuterated forms (d1-d4) 2012-02-15 0E-12 dmaba-d4-nhs-ester DMABA N-hydroxysuccinimide ester-d4; N-Succinimidyl 4-(dimethylamino)benzoate-d4; 4-(dimethylamino) Benzoic Acid-d4 GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers 0E-12
11218 DMABA-d6 NHS ester New 1175002-04-6 ≥99% deuterated form (d1-d6) 2012-02-07 0E-12 dmaba-d6-nhs-ester DMABA N-hydroxysuccinimide ester-d6; 4-(dimethylamino) Benzoic Acid-d6; N-Succinimidyl 4-(dimethylamino)benzoate-d6 GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers 0E-12
11216 DMABA NHS ester New 58068-85-2 ≥98% 2012-01-19 0E-12 dmaba-nhs-ester N-Succinimidyl 4-(dimethylamino)benzoate; DMABA N-hydroxysuccinimide ester; 4-(dimethylamino) Benzoic Acid phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes MS mass spectrometry electorspray tandem PE lipids markers 0E-12
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated forms (d1-d5) 2005-03-16 218.188360957642 docosahexaenoic-acid-d5 Cervonic Acid-d5; DHA-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 218.188360957642
10006829 Docosahexaenoic Acid Quant-PAK - 2005-08-08 50.848740331491 docosahexaenoic-acid-quant-pak DHA Quant-PAK; Cervonic Acid Quant-PAK Quant-PAKs polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated retinol neuronal membranes neonatal deprivation hypertension neurochemistry packs 50.848740331491
9001108 Docosahexaenoyl Ethanolamide-d4 Exclusive New 946524-43-2 ≥99% deuterated forms (d1-d4) ✓ 2012-02-21 19.810945429872 docosahexaenoyl-ethanolamide-d4 DHEA-d4; DEA-d4 neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry LC/MS MS 19.810945429872
10010671 Donepezil-d7 - ≥99% deuterated forms (d1-d7) 2009-04-15 1.447513812155 donepezil-d7 acetyl cholinesterase inhibitors inhibits inhibition alzheimers disease cortical 120014-06-4 deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 1.447513812155
10253 Doxifluridine New 3094-09-5 ≥95% 2012-01-19 28.333333333333 doxifluridine 5-DFUR 1226642-64-3 5-fluoro-5'-deoxyuridine 5-fluorodesoxyuridine 5-dFUrd flutron furtulon Ro 21-9738 Ro-21-9738 28.333333333333
10010675 Doxifluridine-d2 84258-25-3 ≥99% deuterated forms (d1-d2) 2009-08-05 11.474769797421 doxifluridine-d2 5-DFUR-d2 SPI BIO deuterated 5DFUR 5 DFUR mass spectrometry 5-DFCR 5-DFUR 5,-deoxy-5-fluorocytidine 5'-DFCR 5'-DFUR 5'-deoxy-5-fluororidine prodrug 5-fluororacil 154361-50-9 11.474769797421
10005056 Eicosapentaenoic Acid-d5 145191-14-6 ≥99% deuterated forms (d1-d5) 2005-08-30 291.556055248619 eicosapentaenoic-acid-d5 EPA-d5; Timnodonic Acid-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory 291.556055248619
10011721 ent-8-iso Prostaglandin F2α-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2008-08-11 17.947384898710 ent-8-iso-prostaglandin-f2-d9 ent-8-epi PGF2α-d9; ent-15-F2t-Isoprostane-d9; ent-8-iso PGF2α-d9 deuterated deuterium inhibitors inhibits inhibition 8-iso-PGF2.alpha. vasoconstriction platelet aggregation oxidative stress isoprostanes 15-F2t-isoprostane GC/MS GC-MS LC/MS LC-MS mass spectrometry 17.947384898710
10919 (±)-epi CP 47, 497 - ≥98% 2011-05-05 9.598423751790 -epi-cp-47-497 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 9.598423751790
13801 (±)-epi CP 47,497 (solution) Exclusive - ≥98% ✓ 2010-08-04 9.334116612362 -epi-cp-47-497-solution 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 9.334116612362
10010654 Felodipine-d3 - ≥99% deuterated forms (d1-d3) 2009-04-17 0E-12 felodipine-d3 pharmaceutical reference standard blood pressure smooth muscle deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
316767 Fluprostenol-d4 - ≥99% deuterated forms (d1-d4) 0E-12 fluprostenol-d4 16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry (+)-fluprostenol prostaglandins deuterated 0E-12
9000497 GW 9662-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2009-09-30 33.777096378146 gw-9662-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs 33.777096378146
10570 Heneicosapentaenoic Acid-d6 - ≥99% deuterated forms (d1-d6) 2010-12-13 37.391514903485 heneicosapentaenoic-acid-d6 24257-10-1 c21:5 C-21:5 C 21:5 omega-3 .omega.-3 w-3 deterateds deuteriums standards mass spectrometry LC/MS GC/MS LC-MS GC-MS MS 37.391514903485
11622 Heneicosapentaenoic Acid methyl ester Exclusive New 65919-53-1 ≥98% ✓ 2012-04-23 101.111111111110 heneicosapentaenoic-acid-methyl-ester HPA methyl ester fatty acids EPA DHA arachidonic linoleic PGH synthases 5-LO prodrugs 5-LOX LO LOX prostaglandins PGs HPA Bryopsis pennata Lamouroux green algae fish oils eicosapentaenoic docosahexaenoic phospholipids 5-lipoxygenases 5 lipoxygenases 101.111111111110
10010676 Hydrochlorothiazide-d2 15N2 - ≥99% deuterated forms (d1-d2) 2009-05-02 0E-12 hydrochlorothiazide-d2-15n2 58-93-5 8049-49-8 125727-50-6 edema hypertension diabetes deuterated deuterium 0E-12
10010674 Hydroxyalprazolam-d5 136765-24-7 ≥99% deuterated forms (d1-d5) 2009-06-30 0E-12 hydroxyalprazolam-d5 deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry triazolobenzodiazepine anti-anxiet antianxiety sedative hypnotic panic disorders 0E-12
316300 iPF2α-VI-d4 214977-79-4 ≥99% deuterated forms (d1-d4) 39.123701657458 ipf2-vi-d4 8-iso-5(R),6E,14Z-Prostaglandin F2α-d4 deuteriums isotopes 8-isoprostanes iPF2.alpha.-VI-d4 iPF2alpha-VI-d4 lipid peroxidation oxidative ipf2a injury stress prostaglandins deuterated iPF2a-VI-d4 pgf2a deuterium GC/MS GC-MS LC/MS LC-MS mass specrometry 39.123701657458
10486 JWH 007-d9 - ≥99% deuterated forms (d1-d9) 2010-10-11 38.180851749539 jwh-007-d9 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 38.180851749539
10660 JWH 015-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-02-21 44.219281767956 jwh-015-d7 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 44.219281767956
10711 JWH 018 2-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-02-25 12.710481456396 jwh-018-2-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 12.710481456396
10712 JWH 018 4-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-02-25 15.974211548210 jwh-018-4-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 15.974211548210
10713 JWH 018 5-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-03-11 16.057740414512 jwh-018-5-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 16.057740414512
10714 JWH 018 6-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-03-25 29.737593084863 jwh-018-6-hydroxyindole-metabolite-d9 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.737593084863
10715 JWH 018 7-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-07-26 8.456755434286 jwh-018-7-hydroxyindole-metabolite-d9 WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 8.456755434286
13824 JWH 018-d9 (solution) - ≥99% deuterated forms (d1-d9) 2010-06-21 48.264956879881 jwh-018-d9-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 48.264956879881
10926 (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-06-28 48.189223825681 -jwh-018-n-4-hydroxypentyl-metabolite-d5 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 48.189223825681
10933 JWH 018 N-(5-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-06-22 65.383411098240 jwh-018-n-5-hydroxypentyl-metabolite-d5 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 65.383411098240
9000867 JWH 018 N-pentanoic acid metabolite-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-09-15 231.759091679792 jwh-018-n-pentanoic-acid-metabolite-d4 JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 231.759091679792
10716 JWH 073 2-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-10 13.307377506650 jwh-073-2-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 13.307377506650
10717 JWH 073 4-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-02-21 6.044669013027 jwh-073-4-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 6.044669013027
10718 JWH 073 5-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-11 10.114667254961 jwh-073-5-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 10.114667254961
10719 JWH 073 6-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-11 5.957007871222 jwh-073-6-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 5.957007871222
10720 JWH 073 7-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-07-25 2.962005138349 jwh-073-7-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 2.962005138349
9000868 JWH 073-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2010-08-10 34.439604184391 jwh-073-d7-solution deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 34.439604184391
10934 JWH 073 N-(4-hydroxybutyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-10-14 60.928260173248 jwh-073-n-4-hydroxybutyl-metabolite-d5 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices 60.928260173248
10511 JWH 081-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 34.895498379446 jwh-081-d9 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 34.895498379446
10512 JWH 122-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 82.701417264663 jwh-122-d9 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 82.701417264663
11475 JWH 122 N-(5-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-04-27 177.815253720284 jwh-122-n-5-hydroxypentyl-metabolite-d5 MAM2201 N-(5-hydroxypentyl) metabolite-d5 LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids cbs synthetic receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 177.815253720284
10903 JWH 200-d5 - ≥99% deuterated forms (d1-d5) 2011-05-06 7.401256906077 jwh-200-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 7.401256906077
10682 JWH 200-d5 (solution) - ≥99% deuterated forms (d1-d5) 2011-01-07 35.027270718231 jwh-200-d5-solution cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 35.027270718231
10510 JWH 210-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 28.281393228426 jwh-210-d9 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain 28.281393228426
10661 JWH 250-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-02-14 37.389532481263 jwh-250-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 37.389532481263
11474 JWH 250 N-(5-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-04-27 122.875777105692 jwh-250-n-5-hydroxypentyl-metabolite-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS synthetic JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum JWH-18 JWH 18 JWH18 JWH018 JWH-018 JWH 018 JWH 15 JWH-15 JWH15 JWH015 JWH-015 JWH 015 122.875777105692
10514 JWH 398-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-08-25 38.562490444706 jwh-398-d9 JWH398 JWH-398 standards cannabinoids CBs JWHs forensics sciences deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 38.562490444706
10006556 Latanoprost-d4 - ≥99% deuterated forms (d1-d4) 2005-11-30 37.020092081030 latanoprost-d4 17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4 isopropyl ester eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17-phenyl-13,14-dihydro-trinor-PGF2.alpha.-d4 17-phenyl-13,14-dihydro-trinor-PGF2alpha-d5 17-phenyl-13,14-dihydro trinor-PGF2a-d4 PGs 37.020092081030
316822 Latanoprost ethyl amide-d4 - ≥99% deuterated forms (d1-d4) 2006-03-16 93.358439226519 latanoprost-ethyl-amide-d4 Lat-NEt-d4 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry 93.358439226519
316811 Latanoprost (free acid)-d4 - ≥99% deuterated forms (d1-d4) 70.356774861878 latanoprost-free-acid-d4 PhXA 85-d4; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4; Lat-FA-d4 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17-phenyl-13,14-dihydro-trinor-PGF2.alpha.-d4 PhXA85-d4 17-phenyl-13,14-dihydro-trinor-PGF2alpha-d5 LatFA-d4 17-phenyl-13,14-dihydro trinor-PGF2a-d4 70.356774861878
320110 Leukotriene B4-d4 - ≥99% deuterated forms (d1-d4) 143.486187845304 leukotriene-b4-d4 LTB4-d4 GC/MS LTB4-d4 deuterium internal standards isotopes leukotrienes GC-MS mass spectrometry LC/MS LC-MS deuterated spectroscopy atherosclerosis mass spectrometry 143.486187845304
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 29.751524861878 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 29.751524861878
10006198 Leukotriene C4-d5 - ≥99% deuterated forms (d1-d5) 2007-04-11 154.699889502763 leukotriene-c4-d5 LTC4-d5 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry 154.699889502763
10007241 Leukotriene C4 Lipid Maps MS Standard 72025-60-6 >97% 2009-01-07 45.879165131982 leukotriene-c4-lipid-maps-ms-standard LTC4 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs MS mass spectrometry standards asthma cyslts 45.879165131982
10006199 Leukotriene D4-d5 - ≥99% deuterated forms (d1-d5) 2008-04-23 52.451625887924 leukotriene-d4-d5 LTD4-d5 peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry 52.451625887924
10007858 Leukotriene E4-d5 - ≥99% deuterated forms (d1-d5) 2008-04-08 110.897298956415 leukotriene-e4-d5 LTE4-D5 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry 110.897298956415
10007242 Leukotriene E4 Lipid Maps MS Standard 75715-89-8 >97% 2009-01-06 56.993003157064 leukotriene-e4-lipid-maps-ms-standard LTE4 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes LTs MS mass spectrometry standards 56.993003157064
390150 Linoleic Acid-d4 Exclusive 79050-23-0 ≥99% deuterated forms (d1-d4) ✓ 9.927914364641 linoleic-acid-d4 standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids 9.927914364641
9000553 Linoleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-01-13 2.351657458564 linoleoyl-ethanolamide-d4 cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic 2.351657458564
360906 Lyso-PAF C-16-d4 - ≥99% deuterated forms (d1-d4) 5.767182320442 lyso-paf-c-16-d4 Lyso-Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated lyso-PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors 5.767182320442
10010228 Lyso-PAF C-18 -d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-11-03 18.899071823204 lyso-paf-c-18-d4 PAFs platelet-activating factors deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 18.899071823204
9001141 Meconin-d3 New - ≥99% deuterated forms (d1-d3) 2012-02-29 81.657179224372 meconin-d3 Opianyl-d3; NSC 35547-d3 meconine opium heroin urinary urine metabolites forensics science opiates NSC-35547 NSC35547 oplanyl EINECS 209-311-8 6,7-dimethoxyphthalide maconine mekonin lactones deuterateds deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS 81.657179224372
10679 Methylenedioxy Pyrovalerone-d8 (hydrochloride) 1246820-09-6 ≥99% deuterated product 2011-02-15 24.109879362481 methylenedioxy-pyrovalerone-d8-hydrochloride MDPV-d8 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs deuterateds deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry MS standards 24.109879362481
10010660 Mifepristone-d3 - ≥99% deuterated forms (d1-d3) 2009-03-04 0E-12 mifepristone-d3 84371-65-3 SPI BIO normal deuterated progestional glucocorticoid hormone agonist hypercortisolism cushing syndrome 0E-12
10010333 Misoprostol (free acid)-d5 - ≥99% deuterated forms (d1-d5) 2008-01-16 15.934723756906 misoprostol-free-acid-d5 PGE1 analogs agonists EP2 EP3 EP4 cytotec cytoprotection SC-29333 SC29333 receptors RU486 RU-486 deuterated deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry 15.934723756906
10007899 N-butyryl-L-Homoserine lactone-d5 - ≥99% deuterated forms (d1-d5) 2006-05-05 15.902984918620 n-butyryl-l-homoserine-lactone-d5 C4-HSL-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence slime biofilms transduction activation signalling 15.902984918620
10007897 N-hexanoyl-L-Homoserine lactone-d3 - ≥99% deuterated forms (d1-d3) 2006-05-05 16.918012667363 n-hexanoyl-l-homoserine-lactone-d3 C6-HSL-d3 GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence cystic fibrosis slime biofilms agriculture aquaculture food spoilage septicemia fish activation transduction signalling 16.918012667363
10010653 Nisoldipine-d4 1219795-47-7 ≥99% deuterated forms (d1-d4) 2009-04-15 0E-12 nisoldipine-d4 63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
9001143 Norsufentanil-d3 Exclusive New 1204688-16-3 ≥99% deuterated forms (d1-d3) ✓ 2012-04-27 161.351168073780 norsufentanil-d3 R 30451-d3 deuterateds deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS noralfentanil R30451 R-30451 opioids metabolites forensics cytochromes P450 CYP450 pain anesthesia synthetics sufentanil livers isoforms P-450 P 450 161.351168073780
9000432 Oleic Acid-d17 - ≥99% deuterated forms (d1-d17) 2010-08-30 3.727113259668 oleic-acid-d17 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids monounsaturated 9Z-octadecenoic Acid cis-9-Octadecenoic Oleic Acids 12-hydroxy Oleic Acids, 12 hydroxy cis-9-Octadecenoic Acid cis 9 Octadecenoic Acid Acids, 12-hydroxy Oleic 12-hydroxy Oleic Acids Acid 9-Octadecenoic Acids Octadecenoic 9-Octadecenoic Acid 9 Octadecenoic Acid Octadecenoic Acids Acids Ricinoleic Ricinoleic Acids Acids Oleic Oleic Acids Acid Oleic Oleic Acid Oleate 3.727113259668
10007823 Oleoyl Ethanolamide-d2 - ≥99% deuterated forms (d1-d2) 2006-03-06 17.913535911602 oleoyl-ethanolamide-d2 OEA-d2; Oleic Acid Ethanolamide-d2 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic 17.913535911602
9000552 Oleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1- d4) ✓ 2010-01-12 10.248737174428 oleoyl-ethanolamide-d4 Oleic Acid Ethanolamide-d4; OEA-d4 cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic 10.248737174428
9000694 Oleoyl Serotonin-d17 Exclusive - ≥99% deuterated forms (d1-d17) ✓ 2010-09-27 6.470165745857 oleoyl-serotonin-d17 N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA deuterateds deuteriums MS mass spectrometry GC-MS LC-MS GC/MS LC/MS standards 6.470165745857
360900 PAF C-16-d4 - ≥99% deuterated forms (d1-d4) 16.246022099448 paf-c-16-d4 Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis 16.246022099448
10010229 PAF C-18-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-11-03 18.859116022099 paf-c-18-d4 PAFs platelet-activating factors atherosclerosis deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 18.859116022099
9000431 Palmitoleic Acid-d14 Exclusive - ≥99% deuterated forms (d1-d14) ✓ 2009-12-04 10.224696132597 palmitoleic-acid-d14 deuteriums GC/MS internal isotopes standards LC/MS mass spectrometry fatty acids deuterateds GC-MS LC-MS MS 10.224696132597
10007824 Palmitoyl Ethanolamide-d4 Exclusive 1159908-45-8 ≥99% deuterated forms (d1-d4) ✓ 2006-03-06 12.649668508287 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-7,7,8,8-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic 12.649668508287
9000551 Palmitoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-01-20 6.165601157590 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4 endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids cbs synthetic 6.165601157590
9000573 Palmitoyl Ethanolamide-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2010-03-04 5.393704726826 palmitoyl-ethanolamide-d5 PEA-15,15,16,16,16-d5; Palmidrol-d5 endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs synthetic 5.393704726826
310210 Prostaglandin A2-d4 - ≥99% deuterated forms (d1-d4) 5.196758747698 prostaglandin-a2-d4 Medullin-d4; PGA2-d4 GC/MS deuterium isotopes PGA2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neuroscience 5.196758747698
10007199 Prostaglandin A2 Lipid Maps MS Standard - ≥98% 2008-07-01 3.667955801105 prostaglandin-a2-lipid-maps-ms-standard Medullin; PGA2 PGA2 prostaglandins vasodilation mass spectrometry 3.667955801105
311210 Prostaglandin B2-d4 - ≥99% deuterated forms (d1-d4) 14.214143646409 prostaglandin-b2-d4 PGB2-d4 GC/MS deuterium isotopes PGB2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 14.214143646409
10007201 Prostaglandin B2 Lipid Maps MS Standard 13367-85-6 >99% 2008-10-24 41.434518109269 prostaglandin-b2-lipid-maps-ms-standard PGB2 PGB2 prostaglandins vasodilation mass spectrometry GC LC MS standards 41.434518109269
312000 Prostaglandin D1-d4 - ≥99% deuterated forms (d1-d4) 0.116906077348 prostaglandin-d1-d4 PGD1-d4 GC/MS deuterium isotopes PGD1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 0.116906077348
312010 Prostaglandin D2-d4 - ≥99% deuterated forms (d1-d4) 52.674930939227 prostaglandin-d2-d4 PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience 52.674930939227
10007272 Prostaglandin D2-d4 Lipid Maps MS Standard - ≥99% deuterated forms (d1-d4) 2009-02-26 45.215165745857 prostaglandin-d2-d4-lipid-maps-ms-standard PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience MS mass spectrometry standards 45.215165745857
10010123 Prostaglandin D2-d9 - ≥99% deuterated forms (d1-d9) 2007-10-25 46.889442425124 prostaglandin-d2-d9 PGD2-d9 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma 46.889442425124
10007203 Prostaglandin D2 Ethanolamide Lipid Maps MS Standard 398138-28-8 >96% 2008-10-29 29.459463299131 prostaglandin-d2-ethanolamide-lipid-maps-ms-standard PGD2-EA anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides GC LC mass spectrometry MS standards 29.459463299131
10007202 Prostaglandin D2 Lipid Maps MS Standard 41598-07-6 >99% 2008-10-27 15.401542711432 prostaglandin-d2-lipid-maps-ms-standard PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS 15.401542711432
313010 Prostaglandin E1-d4 - ≥99% deuterated forms (d1-d4) 26.785285451197 prostaglandin-e1-d4 Alprostadil-d4; PGE1-d4 GC/MS deuterium isotopes PGE1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry atherosclerosis 26.785285451197
314010 Prostaglandin E2-d4 - ≥99% deuterated forms (d1-d4) 105.329093922652 prostaglandin-e2-d4 Dinoprostone-d4; PGE2-d4 GC/MS deuterium isotopes PGE2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 105.329093922652
10007273 Prostaglandin E2-d4 Lipid Maps MS Standard - ≥99% deuterated forms (d1-d4) 2009-02-26 60.696740331491 prostaglandin-e2-d4-lipid-maps-ms-standard Dinoprostone-d4; PGE2-d4 GC/MS deuterium isotopes PGE2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry MS mass spectrometry standards 60.696740331491
10581 Prostaglandin E2-d9 - ≥99% deuterated forms (d1-d9) 2010-09-16 96.365778084715 prostaglandin-e2-d9 PGE2-d9; Dinoprostone-d9 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards 96.365778084715
10007212 Prostaglandin E2 Ethanolamide Lipid Maps MS Standard 194935-38-1 >98% 2008-11-05 33.395580110497 prostaglandin-e2-ethanolamide-lipid-maps-ms-standard Dinoprostone Ethanolamide; Prostamide E2; PGE2-EA anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides GC-MS GC/MS LC-MS LC/MS mass spectromatory standards 33.395580110497
10007211 Prostaglandin E2 Lipid Maps MS Standard 363-24-6 >99% 2008-11-05 17.902946593001 prostaglandin-e2-lipid-maps-ms-standard Dinoprostone; PGE2 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 17.902946593001
10008665 Prostaglandin F1α-d9 - ≥99% deuterated forms (d1-d9) 2006-08-04 8.376869244935 prostaglandin-f1-d9 PGF1α-d9 GC/MS deuterium isotopes PGF1a-d4 PGF1alpha-d4 PGF1.alpha.-d9 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 8.376869244935
316010 Prostaglandin F2α-d4 34210-11-2 ≥99% deuterated forms (d1- d4) 27.816883977900 prostaglandin-f2-d4 Dinoprost-d4; PGF2α-d4 GC/MS deuterium isotopes PGF2a-d4 PGF2alpha-d4 PGF2.alpha.-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry prostaglandin f2a d4 27.816883977900
10007275 Prostaglandin F2α-d4 Lipid Maps MS Standard 34210-11-2 ≥99% deuterated forms (d1-d4) 2009-02-26 15.032309392265 prostaglandin-f2-d4-lipid-maps-ms-standard Dinoprost-d4; PGF2α-d4 GC/MS deuterium isotopes PGF2a-d4 PGF2alpha-d4 PGF2.alpha.-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 15.032309392265
10008643 Prostaglandin F2α-d9 - ≥99% deuterated forms (d1-d9) 2006-08-04 29.466616942909 prostaglandin-f2-d9 Dinoprost-d9 GC/MS deuterium PGF2.alpha.-d9 PGF2alpha-d9 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated PGF2a-d9 29.466616942909
316013 Prostaglandin F2α Ethanolamide-d4 - ≥99% deuterated forms (d1-d4) 12.766395027624 prostaglandin-f2-ethanolamide-d4 PGF2α-EA-d4; Dinoprost Ethanolamide-d4 ethanolamides cannabinoids prostaglandins PGF2.alpha. PGF2alpha anandamides AEA COX-2 cox2 cyclooxygenases pghs2 pghs-2 synthases synthase-2 deuterium deuterated neuroscience ethanolamines prostamides GC/MS GC-MS LC/MS LC-MS mass spectrometry 12.766395027624
10007222 Prostaglandin F2α Ethanolamide Lipid Maps MS Standard 353787-70-9 >99% 2008-12-08 19.149509668508 prostaglandin-f2-ethanolamide-lipid-maps-ms-standard PGF2α-EA; Dinoprost Ethanolamide ethanolamides cannabinoids prostaglandins PGF2.alpha. PGF2alpha anandamides AEA COX-2 cox2 cyclooxygenases pghs2 pghs-2 synthases synthase-2 neuroscience ethanolamines prostamides MS mass spectrometry 19.149509668508
10007221 Prostaglandin F2α Lipid Maps MS Standard 551-11-1 >99% 2008-12-13 50.676303867403 prostaglandin-f2-lipid-maps-ms-standard PGF2α; Dinoprost PGF2alpha PGF2.alpha. Lutalyse vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandin f2alpha f2 alpha MS Mass Spectrometry 50.676303867403
10007232 Prostaglandin F2β Lipid Maps MS Standard 4510-16-1 ≥99% 2009-02-03 5.148232044199 prostaglandin-f2-lipid-maps-ms-standard 9β-PGF2α; PGF2β prostaglandins MS mass spectrometry standards PGs inactive PGF2beta PGF2.beta. 5.148232044199
10007230 Prostaglandin G2 Lipid Maps MS Standard - >99% 2008-05-01 64.808756906077 prostaglandin-g2-lipid-maps-ms-standard PGG2 LMFA03010009 endoperoxides cyclooxygenases prostaglandins PGG2 cox-2 PGHS-1 PGHS-2 cox1 cox2 cox-1 synthases PGHS1 PGHS2 lipids mass spectrometry liquid gas chromatography LC- GC- standards 64.808756906077
10007231 Prostaglandin H2 Lipid Maps MS Standard - >99% 2008-05-01 50.999882596685 prostaglandin-h2-lipid-maps-ms-standard PGH2 LMFA03010010 PGH2 endoperoxides cyclooxygenase vasoconstrictors prostaglandins PGHS2 syntahses cox-2 cox2 PGHS-2 atherosclerosis lipids mass spectrometry liquid gas chromatography LC- GC- standards 50.999882596685
10007233 Prostaglandin J2 Lipid Maps MS Standard 60203-57-8 >95% 2009-01-05 23.347190213101 prostaglandin-j2-lipid-maps-ms-standard PGJ2 PGJ2 PGD2 metabolites PPARs prostaglandins peroxisome proliferator-activated receptors MS mass spectrometry standards PGs 23.347190213101
10007236 Prostaglandin K2 Lipid Maps MS Standard - ≥98% 2009-01-16 87.304447513812 prostaglandin-k2-lipid-maps-ms-standard PGK2 PGK2 9,11-diketones prostaglandins PGE2 PGD2 PGs MS mass spectrometry standards 87.304447513812
9000305 PtdIns-(1-arachidonoyl, 2-arachidonoyl-d8) (ammonium salt) Exclusive - ≥99% deuterated forms (d1-d8) ✓ 2009-04-20 15.698350828729 ptdins-1-arachidonoyl-2-arachidonoyl-d8-ammonium-salt arachidonic acids deuterium atoms AA GC/MS LC/MS mass spectrometry deuterateds 15.698350828729
9000304 PtdIns-(1-arachidonoyl-d8, 2-arachidonoyl) (sodium salt) Exclusive - ≥95% ✓ 2009-06-29 0E-12 ptdins-1-arachidonoyl-d8-2-arachidonoyl-sodium-salt arachidonic acids deuterium deuterated phosphatidylinositol internal standards phosphates deuterium GC/MS standards GC-MS LC/MS LC-MS mass spectrometry 0E-12
9000414 PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl)-d62 (sodium salt) Exclusive - ≥98% ✓ 2009-09-25 14.484466638334 ptdins-3-4-5-p3-1-2-dipalmitoyl-d62-sodium-salt Phosphatidylinositol-3,4,5-trisphosphate C-16-d62; DPPI-3,4,5-P3-d62 phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids PIPs phosphatidylinositols triphosphates phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP3 mono di 14.484466638334
10005616 PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt) - ≥99% deuterated product 2005-12-30 13.982187083253 ptdins-3-p1-1-2-dipalmitoyl-d62-ammonium-salt DPPI-3-P-d62; Phosphatidylinositol-3-phosphate C16-d62 phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP1 triphosphates mono 13.982187083253
10005615 PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt) - ≥99% deuterated product 2006-01-30 15.227603059923 ptdins-4-5-p2-1-2-dipamitoyl-d62-sodium-salt Phosphatidylinositol-4,5-diphosphate C16-d62; DPPI-4,5-P2-d62 phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP2 triphosphates mono di 15.227603059923
10534 (R)-Bromoenol lactone-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2010-06-17 7.613259668508 -r-bromoenol-lactone-d7 (R)-BEL-d7 selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based human recombinants deuterium deuterateds GC/MS LC/MS LC-MS GC-MS mass spectrometry MS signalling standards 7.613259668508
10513 RCS-4-d9 - ≥99% deuterated product 2011-09-12 34.954514656230 rcs-4-d9 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 34.954514656230
10010662 Rilmenidine-d4 85047-14-9 ≥99% deuterated product 2009-04-17 0.795580110497 rilmenidine-d4 adrenergic agonist agents antihypertensive deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0.795580110497
10010664 Ropinirole-d7 (hydrochloride) - ≥99% deuterated product 2009-06-30 0E-12 ropinirole-d7-hydrochloride deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry non-ergoline nonergoline dopamines agonist Parkinson's disease Parkinsons restless legs syndrome 0E-12
9000372 S-Adenosylhomocysteine-d4 Exclusive - ≥99% deuterated product ✓ 2009-12-02 19.547237569060 s-adenosylhomocysteine-d4 SAH-d4 deuteriums GC/MS LC/MS mass spectrometry GC-MS LC-MS deuterateds amino acids derivative cysteine methyl cycle biosynthesis 979-92-0 risk factors s-adenosyl-l-homocysteine-d4 19.547237569060
10535 (S)-Bromoenol lactone-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2010-06-17 8.306298342541 -s-bromoenol-lactone-d7 (S)-BEL-d7 selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based vasopression-induced rat aortic smooth muscle A10 deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards 8.306298342541
13830 Synthetic Cannabinoid HPLC Mixture I - ≥95% for each compound 2010-05-13 40.045118847375 synthetic-cannabinoid-hplc-mixture-i cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic 40.045118847375
13850 Synthetic Cannabinoid HPLC Mixture II - ≥95% for each compound 2010-12-21 44.388457144890 synthetic-cannabinoid-hplc-mixture-ii cannabinoids CBs synthetics mixtures receptors agonists synthetic 44.388457144890
11335 Synthetic Cannabinoid HPLC Mixture III New - ≥95% for each compound 2012-03-20 75.250490689850 synthetic-cannabinoid-hplc-mixture-iii cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs RCS 75.250490689850
11336 Synthetic Cannabinoid HPLC Mixture IV New - ≥95% for each compound 2012-05-03 100.564303915699 synthetic-cannabinoid-hplc-mixture-iv cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs 100.564303915699
11337 Synthetic Cannabinoid HPLC Mixture V (AM Series) New - ≥95% for each compound 2012-02-02 40.873690480371 synthetic-cannabinoid-hplc-mixture-v-am-series AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 40.873690480371
10009039 tetranor-PGDM-d6 Exclusive - ≥99% deuterated product ✓ 2007-06-28 47.891203449603 tetranor-pgdm-d6 tetranor-Prostaglandin D Metabolite-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry PGD-M t-PGDM t-prostaglandin 47.891203449603
314840 tetranor-PGEM-d6 Exclusive - ≥99% deuterated product ✓ 70.477634816798 tetranor-pgem-d6 tetranor-Prostaglandin E Metabolite-d6 GC/MS deuterium isotopes tetranor-PGEM-d6 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry metabolites urinary markers PGE-M t-PGEM t-prostaglandin 70.477634816798
10007216 tetranor-PGEM Lipid Maps MS Standard 24769-56-0 ≥98% 2008-12-13 54.427292817679 tetranor-pgem-lipid-maps-ms-standard tetranor-Prostaglandin E Metabolite metabolites urinary markers PGE1 PGE2 urine metabolites MS mass spectrometry standards PGE-M t-PGEM t-prostaglandin 54.427292817679
10007228 tetranor-PGFM Lipid Maps MS Standard 23109-94-6 >98% 2008-12-18 22.958591160221 tetranor-pgfm-lipid-maps-ms-standard tetranor-Prostaglandin F Metabolite metabolites PGF2alpha PGF2.alpha. urinary urine markers PGF2α MS mass spectrometry standards PGF-M t-PGFM t-prostaglandin 22.958591160221
319030 Thromboxane B2-d4 - ≥99% deuterated product 44.321860036832 thromboxane-b2-d4 TXB2-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry atherosclerosis prostaglandins TXB2-d4 thromboxanes deuterated 44.321860036832
10007237 Thromboxane B2 Lipid Maps MS Standard 54397-85-2 ≥99% 2009-01-16 22.881335174954 thromboxane-b2-lipid-maps-ms-standard TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis MS mass spectrometry standards 22.881335174954
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 20.881717311234 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 20.881717311234
13129 trans-trismethoxy Resveratrol-d4 - ≥99% deuterated product 2009-02-09 18.326800184162 trans-trismethoxy-resveratrol-d4 (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins AHR antagonists aryl hydrocarbon receptors 18.326800184162
10010652 Zolpidem-d6 - ≥99% deuterated product 2009-04-17 0E-12 zolpidem-d6 SL 80-0750-d6 insomia GABA gamma-aminobutyric acids receptors nonbenzodiazepine hypnotic deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
9000433 α-Linolenic Acid-d14 - ≥99% deuterated forms (d1-d14) 2010-09-13 8.445831798649 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 8.445831798649
10007234 Δ12-Prostaglandin J2 Lipid Maps MS Standard 87893-54-7 ≥98% 2009-01-20 44.795285451197 -12-prostaglandin-j2-lipid-maps-ms-standard Δ12-PGJ2 delta12-PGJ2 d12-PGJ2 Δ12-PGJ2 antitumor antimitotic PPARgamma PPARγ PPARs peroxisome proliferator-activated receptors prostaglandins ligands MS mass spectrometry standards PGs anti-tumor 44.795285451197
390011 ω-3 Arachidonic Acid-d8 - ≥99% deuterated product 50.047657458563 -3-arachidonic-acid-d8 w-3-AA-d8 GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterium internal isotopes standards deuterated .omega.-3-AA-d8 omega-3-AA-d8 w-3-arachidonic .omega.-3-arachidonic omega-3-arachidonic fatty acids PUFAs polyunsaturated 50.047657458563
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?